Bullish flow in Moderna (MRNA), with shares up $3.31, or 6.65%, near $53.12. Options volume more than double the daily average with 143k contracts traded and calls leading puts for a put/call ratio of 0.58, compared to a typical level near 0.6. Implied volatility (IV30) is higher by 3.9 points near 83.67,in the top quartile of the past year, suggesting an expected daily move of $2.80. Put-call skew flattened, suggesting a modestly bullish tone.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRNA:
- Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
- Moderna Stock (MRNA) Jumps 10% on Positive Results for Cancer Drug
- Moderna curbs investment in vaccine trials due to U.S. backlash, Bloomberg says
- Early notable gainers among liquid option names on January 22nd
- Vanguard S&P 500 ETF (VOO) Daily Update, 1/22/2026